Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.

Internet Explorer 10, Firefox, Chrome, or Safari.

Volunteer Advocate

What We’re Funding

Cystic Fibrosis Canada funds research projects with the greatest potential to advance our understanding and treatment of cystic fibrosis and improve the quality of life for CF patients. Our research programs focus on eight fundamental areas, in addition to targeted programs and partnerships, and training awards. Learn more about our research programs, including detailed summaries of each project currently being funded here

Hover on the graph below to read about the impact of our research programs:

Research Programs Total $5,128,800
Current Therapies
Modifier genes
Research training awards

Impact: Attract, train and retain current and next generation leaders in CF research.

Gene and cell therapy research

Impact: Lead to personalized therapies for cystic fibrosis based on an individual's genetic make-up.

Inflammation research

Impact: Derive new insights into the nature of inflammation and design of novel treatments for CF lung disease.

CFTR protein research

Impact: Identify treatments that correct protein activity, eliminating or ameliorating the symptoms of cystic fibrosis.

Quality of life research

Impact: Improve patient-centered care, understand the complexities of cystic fibrosis, and understand factors leading to increased survival.

Cell membrane channel research

Impact: Provide new avenues to slow progressive lung tissue damage and delay CF lung disease - the main cause of illness and death in cystic fibrosis.

Targeted research programs and partnerships

Impact: Advance CF knowledge and treatment by leveraging funds with partner organizations and institutes, and assembling teams of CF experts to spearhead novel research programs.

Infection research

Impact: Understand the dynamic interactions of microbes in the CF lung in order to identify new therapies that will reduce and prevent lung "flare-ups".

For information about our investments in research and care read our highlights on:

 

Share